CYP2D6 and pharmacogenomics: where does future research need to focus? Part 1: technical aspects
Pharmacogenomics
.
2014 Mar;15(4):407-10.
doi: 10.2217/pgs.14.28.
Authors
Andrea Gaedigk
1
,
J Steven Leeder
Affiliation
1
Division of Clinical Pharmacology & Therapeutic Innovation, Children's Mercy Hospital & Clinics & Department of Pediatrics, University of Missouri-Kansas City, 2401 Gillham Road, Kansas City, MO 64108, USA. agaedigk@cmh.edu.
PMID:
24624906
DOI:
10.2217/pgs.14.28
No abstract available
Publication types
Editorial
MeSH terms
Alleles
Cytochrome P-450 CYP2D6 / genetics*
Humans
Pharmacogenetics / methods
Polymorphism, Single Nucleotide / genetics
Research
Substances
Cytochrome P-450 CYP2D6